Archives of Nephrology and Renal Studies

Commentary Open Access

Peritoneal Imaging may be the Last Piece of the Puzzle for Precision Evaluation of Peritoneal Function

Xiangwen Diao, Xiao Yang

Due to changes in end-stage renal disease (ESRD) policies in many countries and the impact of COVID-19, the importance and demand for peritoneal dialysis (PD) as a home dialysis treatment modality is growing prominently [1]. However, peritoneal membrane dysfunction remains a bottleneck restricting the application of PD. Therefore, there is an urgent need to develop new methods to accurately assess peritoneal function.

Commentary Open Access

The RiVUR Study Outcomes and Implications on the Management of Vesicoureteral Reflux

Tiffany Damm, Ranjiv Mathews

The Randomized intervention for Vesicoureteral Reflux (RiVUR) study was an effort by the National Institute of Health to identify the most significant question on the management of vesicoureteral reflux (VUR), i.e. Did antibiotic prophylaxis reduce the incidence of recurrent urinary tract infections (UTI) in children with VUR? During the initial phases of the RiVUR study, several similar studies were performed that seemed to indicate lack of benefit of antibiotic prophylaxis in VUR.

Research Article Open Access

How Well Do Hemodialysis Patients Respond to the BNT162b2 mRNA COVID-19 Vaccine?

Fernando Carrera, Joana Costa, Luciano Pereira, Marco Marques, Belarmino Spencer, Francisco Ferrer

In January 2020, the World Health Organization (WHO) classified COVID-19 to be a Public Health Emergency of International Concern and declared it a pandemic on March 11, 2020 [1]. Over one hundred and eighty-five million people have been infected by SARS-CoV-2 and roughly four million have died worldwide so far

Short Communication Open Access

Safety of Using Rituximab Therapy During COVID-19 Pandemic

Hatem Ali, Mohammed Elshafey, Mahmoud M Mohamed

Rituximab is a chimeric (20% rodent and 80% human) monoclonal antibody that binds to the CD20 antigen present on the cell surface and leads to depletion of mature B-cells [1,2]. It is the first approved monoclonal antibody to be used in the therapy of indolent B-cell non- Hodgkin’s lymphoma and chronic lymphocytic leukemia

Mini Review Open Access

Percutaneous Ablation of Localized Renal Masses: An Updated Review

Kimberly A. Maciolek, Noah S. Schenkman

With readily available cross-sectional imaging, asymptomatic localized renal masses (LRMs) are often incidentally found. The standard management for LRM has been surgical resection, however, detection of masses that are benign or with low metastatic risk has led to interest in minimally invasive alternatives such as percutaneous thermal ablation (TA) or active surveillance